Tivic Health Systems Inc TIVC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TIVC is a good fit for your portfolio.
News
-
Tivic Reports Fiscal Year 2023 Financial Results
-
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
-
Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation
-
Tivic Enters Exclusive Distribution Agreement with Top 10 Medical Product Distributor for Mass Market Retail
Trading Information
- Previous Close Price
- $1.10
- Day Range
- $1.08–1.13
- 52-Week Range
- $1.00–23.79
- Bid/Ask
- $1.10 / $1.12
- Market Cap
- $1.64 Mil
- Volume/Avg
- 11,802 / 127,616
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body’s own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 16
- Website
- https://www.tivichealth.com
Valuation
Metric
|
TIVC
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.45 |
Price/Sales | 0.74 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
TIVC
|
---|---|
Quick Ratio | 2.55 |
Current Ratio | 3.32 |
Interest Coverage | — |
Quick Ratio
TIVC
Profitability
Metric
|
TIVC
|
---|---|
Return on Assets (Normalized) | −134.06% |
Return on Equity (Normalized) | −186.80% |
Return on Invested Capital (Normalized) | −168.80% |
Return on Assets
TIVC
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wqgmlqwn | Wxknd | $189.5 Bil | |
SYK
| Stryker Corp | Qtbrbxtl | Qrs | $129.0 Bil | |
MDT
| Medtronic PLC | Kdhjcmltz | Jfvqpm | $105.2 Bil | |
BSX
| Boston Scientific Corp | Fqtktrtmj | Hxlgcq | $100.1 Bil | |
EW
| Edwards Lifesciences Corp | Tfyjxvqcl | Kdqpf | $53.7 Bil | |
DXCM
| DexCom Inc | Bggmlnlnp | Mvxxh | $51.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fhgghvfs | Ygtfr | $25.1 Bil | |
ALGN
| Align Technology Inc | Ncvycpgf | Tjvrpkb | $23.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Pyjfqydb | Brbybn | $18.7 Bil | |
PODD
| Insulet Corp | Vmgjvyqtfc | Zqcnqt | $12.1 Bil |